Companies: 10,795·Total market cap: $144.5T
Enhabit, Inc.

Enhabit, Inc.

EHABNYSEHealthcare
$13.80
+$0.01(+0.07%)
Market Cap$706913363
P/E Ratio
52W High$14.22
52W Low$6.47

Enhabit, Inc. (EHAB) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ehab · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Enhabit, Inc. (EHAB) measures how much investors pay for each dollar of the company's trailing earnings. EHAB's current PE ratio of N/A is calculated by dividing its stock price of $13.80 by its TTM earnings per share of -$0.06.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
23.00x
FY2026 est. EPS $0.60
Based on 1 analyst
EPS (TTM)
-$0.06
TTM · diluted EPS
PEG Ratio
-0.67
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Enhabit, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2019 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 2.1x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 3 fiscal years · Front-end computed
Average
2.1x
3-yr mean
Median
1.3x
3-yr midpoint
Minimum
0.9x
Lowest year
Maximum
4.1x
Highest year
0.9x
Min
Q1 · 25%1.3x
Median
Q3 · 75%4.1x
Max
Historically Low

At N/A, EHAB's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.

0th percentileHigher than 0 of 3 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Care Facilities · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Enhabit, Inc.
Enhabit, Inc.You
EHAB
$707MN/A-$0.06
Agilon Health, Inc.
Agilon Health, Inc.
AGL
$1.7BN/A-$24.48
Auna S.A.
Auna S.A.
AUNA
$326M5.10x$3.24
Autolus Therapeutics plc
Autolus Therapeutics plc
AUTL
$385MN/A-$1.08
CeriBell, Inc.
CeriBell, Inc.
CBLL
$703MN/A-$1.46
Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc.
CCRN
$427MN/A-$2.93
OrthoPediatrics Corp.
OrthoPediatrics Corp.
KIDS
$472MN/A-$1.69

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.09
2024-12-31
FY2024
$-3.11
2023-12-31
FY2023
$-1.61
2022-12-31
FY2022
$-0.81
2021-12-31
FY2021
0.88x$28.49-32.5%
2020-12-31
FY2020
1.30x$19.23-68.0%
2019-12-31
FY2019
4.06x$6.15

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Enhabit, Inc. (EHAB) measures how much investors pay for each dollar of the company's trailing earnings. EHAB's current PE ratio of N/A is calculated by dividing its stock price of $13.80 by its TTM earnings per share of -$0.06.

PE Ratio = Stock Price ÷ EPS (TTM)
= $13.80 ÷ -$0.06 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

EHAB pe ratio · 6 questions

EHAB's current PE ratio is N/A as of 2026-06-08, based on a stock price of $13.80 and TTM EPS of -$0.06. Data sourced from Financial Modeling Prep via EHAB's SEC 10-K and 10-Q filings.

EHAB PE ratioWhat is EHAB PE ratioCurrent PE ratio of EHABEHAB PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Enhabit, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08